| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |